Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study.

HIV epidemiology sexuality sexually transmitted infections stigma transgender

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
14 May 2022
Historique:
received: 27 03 2022
revised: 11 05 2022
accepted: 12 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

The burden of sexually transmitted infections (STIs) in the transgender population remains an underestimated issue. The aims of the present study were to evaluate the prevalence of either self-reported and serological STIs and to describe socio-demographic and clinical characteristics of transgender individuals with STIs. A consecutive series of 705 transgender individuals (assigned-male at birth, AMAB n = 377; assigned-female at birth, AFAB n = 328) referring to six Italian gender clinics were included. Sociodemographic and clinical information was collected during the first visit. In a subsample of 126 individuals prevalence of STIs (human immunodeficiency virus, HIV; hepatitis C, HCV; hepatitis B, HBV; syphilis) were evaluated through serology tests. The self-reported prevalence of HIV, HBV, HCV and syphilis infection in the total sample were 3.4%, 1.6%, 2.6% and 2.0%, respectively. In the subsample who underwent serological tests, higher rates of serological prevalence were found (9.5%, 4.0%, 5.6% and 7.9% for HIV, HBV, HCV and syphilis, respectively). When comparing transgender people with or without self-reported STIs, unemployment, previous incarceration, justice problems and sex work resulted more frequent in the first group (p< 0.03 for all). Regarding health status, we observed higher rates of lifetime substance abuse and psychiatric morbidities in trans people with at least one reported STI (p < 0.05). The prevalence of STIs exceeded that reported in general population and STIs correlates underline the importance of stigma and discrimination as determinants of transgender health.

Identifiants

pubmed: 35628902
pii: jcm11102774
doi: 10.3390/jcm11102774
pmc: PMC9147923
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sex Transm Dis. 2016 Jul;43(7):407-11
pubmed: 27322038
J Sex Med. 2013 Feb;10(2):408-19
pubmed: 23171237
Glob Public Health. 2017 Feb;12(2):250-265
pubmed: 26457339
AIDS Behav. 2008 Jan;12(1):1-17
pubmed: 17694429
Transgend Health. 2020 Jun 08;5(2):90-103
pubmed: 32656353
Am J Public Health. 2001 Jun;91(6):915-21
pubmed: 11392934
AIDS Behav. 2009 Oct;13(5):902-13
pubmed: 19199022
Am J Trop Med Hyg. 2003 Jun;68(6):716-20
pubmed: 12887033
Qual Health Res. 2017 Jan;27(2):182-190
pubmed: 26515922
Sex Transm Dis. 2001 Jul;28(7):405-11
pubmed: 11460025
J Adolesc Health. 2006 Mar;38(3):230-6
pubmed: 16488820
Drug Alcohol Depend. 2013 Sep 1;132(1-2):391-4
pubmed: 23510637
AIDS Care. 2004 Aug;16(6):724-35
pubmed: 15370060
Am J Public Health. 2013 May;103(5):943-51
pubmed: 23488522
Am J Public Health. 2013 May;103(5):813-21
pubmed: 23488505
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S74-7
pubmed: 21406991
J Endocrinol Invest. 2017 Mar;40(3):263-273
pubmed: 27639401
Am J Public Health. 2012 Sep;102(9):1751-7
pubmed: 22873480
MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31
pubmed: 16371945
AIDS Behav. 2011 Apr;15(3):650-8
pubmed: 21104008
Sex Transm Infect. 1999 Aug;75(4):273-4
pubmed: 10615320
J Homosex. 2001;42(1):89-101
pubmed: 11991568
Int J Impot Res. 2020 Nov;33(7):687-693
pubmed: 33727693
Int J Infect Dis. 2011 Sep;15(9):e635-40
pubmed: 21742530
Medicine (Baltimore). 2015 Oct;94(41):e1830
pubmed: 26469928
J Med Virol. 2014 Jan;86(1):64-70
pubmed: 24123155
J Sex Med. 2021 Nov;18(11):1933-1944
pubmed: 34749989
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
AIDS Care. 2014;26(7):857-64
pubmed: 24206043

Auteurs

Carlotta Cocchetti (C)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Alessia Romani (A)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Francesca Mazzoli (F)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Jiska Ristori (J)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Filippo Lagi (F)

Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.

Maria Cristina Meriggiola (MC)

Gynecology and Physiopathology of Human Reproduction, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy.

Giovanna Motta (G)

Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Marina Pierdominici (M)

Center for Gender-Specific Medicine, Italian National Institute of Health, 00138 Rome, Italy.

Alessandro Bartoloni (A)

Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.

Linda Vignozzi (L)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Mario Maggi (M)

Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", Careggi University Hospital, University of Florence, 50139 Florence, Italy.

Alessandra Daphne Fisher (AD)

Andrology, Women's Endocrinology and Gender Incongruence Unit, Careggi University Hospital, Viale Pieraccini 6, 50100 Florence, Italy.

Classifications MeSH